Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Her2 Fnr'

Her2 Fnr published presentations and documents on DocSlides.

Managing Breast Cancer in the Genomic Era

Managing Breast Cancer in the Genomic Era

  • alida-meadow
  • 42 Slides

Leisha. A. . Emens. , M.D., . Ph.D. Associate Pr...

Translating NGS Data into a Clinically Actionable Assay

Translating NGS Data into a Clinically Actionable Assay

  • danika-pritchard
  • 41 Slides

Elaine R. Mardis, Ph.D.. Professor of Genetics. C...

What’s new in Anatomic Pathology Quality Assurance?

What’s new in Anatomic Pathology Quality Assurance?

  • alida-meadow
  • 59 Slides

. Raouf E. Nakhleh, MD. Mayo Clinic Florida. Dis...

At the Forefront of Immunotherapy

At the Forefront of Immunotherapy

  • karlyn-bohler
  • 20 Slides

OTCQB: TPIV. 1551 Eastlake Ave E. Suite 100. Seat...

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

  • danika-pritchard
  • 32 Slides

Clinical Practice Guideline Update. American Soci...

Evaluation of HR[ER/

Evaluation of HR[ER/

  • debby-jeon
  • 60 Slides

PgR. ] status and correlation with Ki67 expres...

Chemotherapeutic Treatment Options for Triple Negative Brea

Chemotherapeutic Treatment Options for Triple Negative Brea

  • lois-ondreau
  • 31 Slides

Lauren Barney. April 17, 2013. Breast Cancer Subt...

New Therapies for Metastatic Breast Cancer

New Therapies for Metastatic Breast Cancer

  • alexa-scheidler
  • 70 Slides

Sigrun Hallmeyer, MD. Oncology Specialists, SC. D...

RESEARCHARTICLEOpenAccess

RESEARCHARTICLEOpenAccess

  • alida-meadow
  • 100 Slides

Proposednewclinicopathologicalsurrogate definition...

Metastatic HER2-Positive Breast Cancer: Treatment Selection

Metastatic HER2-Positive Breast Cancer: Treatment Selection

  • test
  • 25 Slides

First . Line and Beyond. Moderator:. Joseph Gligo...

Breast Cancer Highlights From San Antonio

Breast Cancer Highlights From San Antonio

  • tatyana-admore
  • 99 Slides

Joyce O'Shaughnessy, MD. Kimberly Blackwell, MD. ...

William J.

William J.

  • tawny-fly
  • 6 Slides

Gradishar. . MD, FACP. Betsy . Bramsen. Profess...

Chemotherapeutic Treatment Options for Triple Negative Brea

Chemotherapeutic Treatment Options for Triple Negative Brea

  • alida-meadow
  • 30 Slides

Lauren Barney. April 17, 2013. Breast Cancer Subt...

Metastatic Breast Cancer

Metastatic Breast Cancer

  • lindy-dunigan
  • 36 Slides

A sub-focus on specific clinical scenarios. What ...

update in metastatic breast c

update in metastatic breast c

  • min-jolicoeur
  • 27 Slides

. Dr.Mina. . Tajvidi. Radiation . oncologist. ...

RCR breast radiotherapy consensus guidelines

RCR breast radiotherapy consensus guidelines

  • karlyn-bohler
  • 9 Slides

Producing the guidelines. Draft radiotherapy guid...

ID DB06366 CATEGORY

ID DB06366 CATEGORY

  • luanne-stotts
  • 0 Slides

Monoclonal antibodies . PERTUZUMAB . 148 . kDa. ...

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer

  • debby-jeon
  • 0 Slides

Monica Brown, MPH, PhD. . California Cancer Regi...

Evaluation of HR[ER/ PgR

Evaluation of HR[ER/ PgR

  • pasty-toler
  • 0 Slides

] status and correlation with Ki67 expression ...

Genomic/Genetic Testing Germline v Somatic testing and the importance of Molecular Tumor Boards

Genomic/Genetic Testing Germline v Somatic testing and the importance of Molecular Tumor Boards

  • lois-ondreau
  • 0 Slides

Ben Ho Park MD PhD. Johns Hopkins University. Fin...

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

  • danika-pritchard
  • 0 Slides

Clinical Practice Guideline Update. American Soci...

Metastatic Breast Cancer: A Medical Update

Metastatic Breast Cancer: A Medical Update

  • liane-varnes
  • 0 Slides

Jennifer M. Matro, MD. Rena Rowan Breast Center. ...

update in metastatic breast cancer

update in metastatic breast cancer

  • calandra-battersby
  • 0 Slides

. Dr.Mina. . Tajvidi. Radiation . oncologist. ...

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

  • danika-pritchard
  • 0 Slides

ASCO-CAP Recommendations For HER2 Testing in Brea...

Updates in the Treatment of Breast cancer

Updates in the Treatment of Breast cancer

  • alexa-scheidler
  • 0 Slides

Mohammad . Jahanzeb. , MD, FACP. Professor of Cli...

Neoadjuvant Target Therapy in Her-2 Positive Breast Cancer

Neoadjuvant Target Therapy in Her-2 Positive Breast Cancer

  • faustina-dinatale
  • 0 Slides

Dr. . Khaled Abulkhair, PhD. Medical Oncology SCE...

CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data

CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data

  • min-jolicoeur
  • 22 Slides

CDK 4/6 Inhibitors in Breast Cance...

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

  • marina-yarberry
  • 68 Slides

Management of HER2 Over-Expressed Breast Cancer i...

Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications

Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications

  • calandra-battersby
  • 74 Slides

An Interactive Oncology Grand Rounds Series. Joyc...

Moving Evidence into Practice: Breast Cancer Highlights From Chicago

Moving Evidence into Practice: Breast Cancer Highlights From Chicago

  • alida-meadow
  • 28 Slides

This program will include a discussion of off-lab...

Brea st cancer G eneral

Brea st cancer G eneral

  • slayrboot
  • 89 Slides

. in. f. orma. t. ion. Risk. . f. a. ct. ors. Pro...

A case of localized breast cancer

A case of localized breast cancer

  • envrrolex
  • 21 Slides

Antonella Brunello . Kwok-Leung Cheung. Disclosure...

Endocrine resistance: molecular pathways and rational development of targeted therapies

Endocrine resistance: molecular pathways and rational development of targeted therapies

  • spottletoefacebook
  • 66 Slides

Grazia Arpino. Università di Napoli Federico II. ...

Eribulin Mesylate + Trastuzumab

Eribulin Mesylate + Trastuzumab

  • easyho
  • 10 Slides

as First-Line Therapy for Locally Recurrent or . M...

TARGETED CANCER THERAPY IN 2016:

TARGETED CANCER THERAPY IN 2016:

  • bagony
  • 14 Slides

WHAT THE PRACTICING PATHOLOGIST OR ONCOLOGIST NEED...

KER/DAPI KER DAPI CD45 HER2

KER/DAPI KER DAPI CD45 HER2

  • projoutr
  • 1 Slides

A. B. C. D. 0. 1+. 2+. 3+. 3+. 3+. 3+.

Product Pipeline Neratinib

Product Pipeline Neratinib

  • coursion
  • 1 Slides

across the breast cancer therapy spectrum. Phase I...

6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im

6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im

  • katrgolden
  • 50 Slides

Contents PageIntended Use 4Summary and Explanation...

Module 9: HER2-Positive and

Module 9: HER2-Positive and

  • norah
  • 38 Slides

Triple-Negative Breast Cancer. Jamie Carroll, APRN...

20 March 2014EMACHMP1518532014Committee for Medicinal Products for

20 March 2014EMACHMP1518532014Committee for Medicinal Products for

  • nicole
  • 3 Slides

Adoptedby CHMPfor release for consultation20 March...

Copyright © 2024 DocSlides. All Rights Reserved